TB Research

Evaluating the diversity of circulating natural killer cells between active tuberculosis and latent tuberculosis infection

Zhou Y, Lan H, Shi H, Wu P, Zhou Y

Tuberculosis (Edinburgh, Scotland) · 2022-05

Abstract

Tuberculosis (TB) is a leading global public health problem; however, the mechanisms underlying the immunopathology of TB progression are not well understood. It is currently believed that Mycobacterium tuberculosis (Mtb) infection can modify natural killer (NK) cell phenotypic signatures. Hence, our study was designed to investigate the diversity of circulating NK cells in patients with different TB infection status. NK subsets, as well as their expression of activating and inhibitory receptors between active TB (ATB) and latent TB infection (LTBI) were evaluated. There were significant differences in NK cell phenotypes between ATB, LTBI and healthy controls. Notably, the proportion of KLRG1 in NK cells (P = 0.036), as well as in their subsets CD56 Dim CD16+ (P = 0.046) and CD27 + (P = 0.027) NK cells, increased significantly in LTBI group than in ATB group; while Mtb specific IFN-γ+CD56 Bright CD16 Dim NK cells expressed higher KLRG1 in ATB than in LTBI (P = 0.027). However, the expression of activating receptor NKG2D in NK subsets showed no significant difference among the study groups. Our results suggest that different TB infection status are coupled with the diversity of NK cell compartments, and the expression of KLRG1 in NK cells may be a specific phenotype that modulates the progression of TB from latent to active.

MeSH terms

  • Killer Cells, Natural
  • Humans
  • Mycobacterium tuberculosis
  • Tuberculosis
  • Latent Tuberculosis